Association Between Iron Availability and Accelerated Biological Aging in Non-Anemic Women of Reproductive Age: A Nationally Representative Cross-Sectional Study.
Key claim: Higher sTfR index values, reflecting lower iron availability without anemia, were associated with about 1.9 additional years of phenotypic age acceleration per unit increase in non-anemic women aged 20–49.
Abstract
Iron is essential for mitochondrial function, yet iron insufficiency without anemia in reproductive-aged women is often overlooked. Traditional markers like ferritin are influenced by inflammation, which may complicate the assessment of iron status and its association with biological aging. We analyzed 5,686 non-anemic reproductive-aged women (20-49 years) from NHANES cycles 2003-2010 and 2015-2023. We examined the association between the soluble transferrin receptor-to-log(ferritin) index (sTfR index), an indirect marker of iron status, and biological aging, measured by Phenotypic Age Acceleration (PhenoAgeAccel). Analyses included weighted multivariable regression, restricted cubic spline (RCS) modeling, and sensitivity analysis (CRP ≤ 5 mg/L). Each 1-unit increase in sTfR index was associated with a 1.94-year increase in PhenoAgeAccel (95% CI: 1.56-2.32). The association remained robust after excluding participants with elevated inflammation (β = 1.79; 95% CI: 1.41-2.17). Separately, ferritin RCS analysis showed that compared with the median (47 μg/L), women at the WHO threshold (15 μg/L) exhibited 1.93 additional years of biological aging (95% CI: 1.58-2.29). Notably, women with higher sTfR index values (median ferritin 29 μg/L) showed PhenoAgeAccel values, despite a substantial proportion having ferritin levels above commonly used deficiency thresholds. The magnitude of this association varied across levels of bilirubin and socioeconomic status. Higher sTfR index values, even in the absence of anemia, were associated with accelerated biological aging in reproductive-aged women. The sTfR index may provide additional information regarding iron status beyond conventional markers.
Why this matters
PhenoAge is built from standard clinical labs, so identifying a common, cheap analyte (sTfR index) that flags accelerated phenotypic aging in an ostensibly healthy demographic — non-anemic women of reproductive age — expands the measurable risk terrain below the conventional anemia cutoff. It also highlights a sex- and life-stage-specific signal that a sex-neutral risk panel would miss, though this is a cross-sectional association and does not demonstrate that correcting iron availability lowers biological age.